Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
02/2011
02/24/2011US20110046171 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists
02/24/2011US20110046158 Capped pyrazinoylguanidine sodium channel blockers
02/24/2011US20110046155 Hydrobenzamide derivatives as inhibitors of hsp90
02/24/2011US20110046148 Spirocyclic Heterocycles Medicaments Containing Said Compounds, Use Thereof And Method For Their Production
02/24/2011US20110046137 Pyrazole Derivatives as P2X7 Modulators
02/24/2011US20110046133 Organic compounds
02/24/2011US20110046132 Benzoimidazoles as prolyl hydroxylase inhibitors
02/24/2011US20110046113 Amine compound and use thereof
02/24/2011US20110046108 Pyrimidine derivatives
02/24/2011US20110046106 Aryl sulfonamides as effective analgesics
02/24/2011US20110046104 Aminopyrimidines useful as kinase inhibitors
02/24/2011US20110046000 Methods to increase the photostability of dyes
02/24/2011US20110045104 3-[1-(3-Haloalkyl)triazolyl]phenyl sulphide derivatives as acaricides and insecticides
02/24/2011US20110045101 Fungicidal substituted azoles
02/24/2011US20110042654 Organic compound, and organic photoelectric device comprising the same
02/24/2011US20110041263 Azomethine direct dyes or reduced precursors of azomethine direct dyes obtained from 2-alkylresorcinols, and hair dyeing process using these dyes or precursors
02/24/2011US20110041261 Azomethine direct dyes or reduced precursors of these dyes obtained from 2-chloro-3-amino-6-methylphenol, and hair dyeing method starting from these dyes and precursors
02/24/2011CA2771609A1 Substituted benzoazepines as toll-like receptor modulators
02/24/2011CA2771579A1 Nitrogen-containing compound and pharmaceutical composition
02/24/2011CA2771484A1 Substituted benzoazepines as toll-like receptor modulators
02/24/2011CA2771234A1 Substituted hydrazide compounds and use thereof
02/24/2011CA2771190A1 Heat shock protein binding compounds, compositions, and methods for making and using same
02/24/2011CA2770454A1 Biaryl compounds and methods of use thereof
02/23/2011EP2287156A1 2,4-Di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
02/23/2011EP2285802A1 Oxo-imidazolyl compounds having antibacterial activity
02/23/2011EP2285801A1 Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides
02/23/2011EP2285789A1 Novel substituted pyrazoles, 1,2,4-oxadiazoles, and 1,3,4-oxadiazoles
02/23/2011EP2285787A2 3-substituted propanamine compounds
02/23/2011EP2285785A1 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of arway diseases
02/23/2011EP1958946B1 Pyridazine compound and use thereof
02/23/2011EP1819698B1 1-[(6-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives
02/23/2011EP1737843B1 Inhibitors of akt activity
02/23/2011EP1682520B1 Amide derivatives
02/23/2011EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity
02/23/2011EP1227805B2 Mediators of hedgehog signaling pathways, compositions and uses related thereto
02/23/2011EP1031571B1 Sulfamoyl compounds and agricultural or horticultural bactericide
02/23/2011CN1882549B 7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors
02/23/2011CN101981010A 酰胺化合物 Amide compounds
02/23/2011CN101981006A Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
02/23/2011CN101979382A Aminoindazole derivatives and use thereof as kinase inhibitors
02/23/2011CN101039907B Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
02/22/2011US7893279 Cyclohexanecarboxylic acid compound
02/22/2011US7893278 Antiproliferative agents; antitumor agents; anticancer agents
02/22/2011US7893269 Process for the manufacture of 3-hydroxy-N-alkyl-1-cycloalky1-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
02/22/2011US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists
02/22/2011US7893084 Viral polymerase inhibitors
02/22/2011US7893077 Bisaryl-sulfonamides
02/22/2011US7893074 inhibition of focal adhesion kinase or/and IGF-1 Receptor; for example: 2-[2-(2,5-Dimethoxy-phenylamino)-5-nitro-pyrimidin-4-ylamino]-N-methyl-benzenesulfonamide
02/22/2011US7893064 N-[1-(3-fluoro-benzyl)-1H-indazol-5-yl]-5-[(4-methoxy-phenyl)-hydrazonomethyl]-pyrimidine-4,6-diamine; inhibitors of ATP-protein kinase interactions; antiinflammatory, anticarcinogenic, antidiabetic agent; neurodegenerative diseases
02/22/2011US7893063 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
02/22/2011CA2553879C Viral polymerase inhibitors
02/22/2011CA2522486C Bromide and crystals thereof
02/22/2011CA2476296C Amino-derivatives as inhibitors of histone deacetylase
02/22/2011CA2319198C Substituted oxoazaheterocyclyl factor xa inhibitors
02/17/2011WO2011019405A1 Pyrimidine compounds as tuberculosis inhibitors
02/17/2011WO2011019060A1 Hedgehog signal inhibitor
02/17/2011WO2011018790A1 Polycyclic compounds, termed calixurenes, and uses thereof
02/17/2011WO2011018417A1 Inhibitors of jnk
02/17/2011WO2010124097A3 Transcription factor modulating compounds and methods of use thereof
02/17/2011WO2010115125A3 Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
02/17/2011US20110040090 Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides
02/17/2011US20110039872 Deuterium-enriched capecitabine
02/17/2011US20110039871 Process for preparing bosentan
02/17/2011US20110039864 Therapeutic compounds
02/17/2011US20110039860 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
02/17/2011US20110039855 Tetrahydrocyclopenta[b]indole Androgen Receptor Modulators
02/17/2011US20110039847 Amide derivatives as sirtuin modulators
02/17/2011US20110039845 2-aminoquinazoline derivative
02/17/2011US20110039839 Cyanopyrroles
02/17/2011US20110039833 1-benzoyl substituted diazepine derivatives as selective histamine h3 receptor agonists
02/17/2011US20110039830 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
02/17/2011US20110039829 Pyrazole-carboxamide derivatives as p2y12 antagonists
02/17/2011US20110039827 Substituted hydroxamic acids and uses thereof
02/17/2011US20110039821 Fused Phenyl Amido Heterocyclic Compounds
02/17/2011US20110039817 4-aminopyrimidine derivatives as histamine h4 receptor antagonists
02/17/2011US20110039802 Npy y5 antagonist
02/17/2011US20110039695 Substituted Pyridazinylmethyl Sulfonamides
02/17/2011US20110039693 Pyrimidylmethyl Sulfonamide Compounds
02/17/2011US20110039109 Activator for epoxy resin compositions
02/17/2011US20110038803 specifically and efficiently traps nitrogen monoxide, zinc ion etc. to emit fluorescence; used to measure nitrogen monoxide or metal ions in a deep tissue of a living body
02/17/2011US20110037027 Fluorine derivatives for organic electroluminescence devices
02/17/2011US20110036975 Imidazolium-based liquid salts and methods of use thereof
02/17/2011CA2770724A1 Compounds and methods of use thereof
02/17/2011CA2768749A1 Inhibitors of jnk
02/16/2011EP2284166A1 Arylsulfonamides with analgetic activity
02/16/2011EP2283010A1 Process for preparing intermediate compound for synthesizing an antiulcerant
02/16/2011EP2282999A1 Amino-quinoxaline and amino-quinoline compounds for use as adenosine a2a receptor antagonists
02/16/2011EP2282995A1 Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
02/16/2011EP2155729B1 Prolinamide-tetrazole derivatives as nk3 receptor antagonists
02/16/2011EP2046762B1 Triazolyl phenyl benzenesulfonamides
02/16/2011EP1847570B1 Colorant, ink, ink-jet ink, method of ink-jet recording, color toner, and color filter
02/16/2011EP1771422B1 Quinazolinone derivatives as parp inhibitors
02/16/2011EP1664035B1 2,4 di(hetero)-arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
02/16/2011EP1309568B1 [(quinazolin-4-yl)piperazin-4-yl]thiocarboxamide compounds as inhibitors of the phosphorylation of a PDGF receptor
02/16/2011CN1989113B Quinazoline derivatives
02/16/2011CN1972926B Indole derivatives as histamine receptor antagonists
02/16/2011CN101977909A Dexlansoprazole process and polymorphs
02/16/2011CN101977908A (pyrazolyl carbonyl)imidazolidinone derivatives for the treatment of retroviral diseases
02/16/2011CN101977907A Pyrrolidinyl derivatives and uses thereof
02/16/2011CN101977900A 5-fluoro pyrimidine derivatives